Target intelligence / Profile preview

Serpin family A member 9 (SERPINA9)

Target
SERPINA9
Molecular classification
Serine protease inhibitor (serpin superfamily), Enzyme inhibitor
01

Overview

Serpin family A member 9 (SERPINA9) is a member of the serpin superfamily of serine protease inhibitors, with prominent expression restricted to germinal center B cells of lymphoid tissue. The protein, also known as centerin or GCET1, inhibits trypsin-like proteases efficiently, and shows some inhibitory activity against plasmin and thrombin. Biophysical analyses reveal a conserved serpin domain and conformational dynamics essential for its inhibitory function. SERPINA9 serves as a highly specific marker for germinal center B-cells in both health and in lymphoid cancers, supporting diagnostic distinction between tumor subtypes like follicular lymphoma and some Hodgkin lymphomas. Genetic variation in SERPINA9 may predispose individuals to cardiovascular disease, such as ischemic stroke. No direct drugs targeting SERPINA9 are currently noted, but its presence and expression are exploited in clinical pathology as biomarkers.

Other names
Serpin A9centerinGCET1SERPINA11SERPINA11bgerminal center B-cell-expressed transcript 1 proteinserine proteinase inhibitor A11serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9SPA9SPA9_HUMAN
02

Mechanism of action

Protease inhibition: drugs or biologics could affect its interaction with target proteases (trypsin-like, thrombin, plasmin), but no specific drug established

03

Biological functions

Protease inhibition (trypsin, plasmin, thrombin)Regulation of germinal center B-cell biologyImmune response (marker and regulator in germinal center B cells)
04

Disease associations

Cancer (lymphoid malignancies, follicular lymphoma, diffuse large B-cell lymphoma, Hodgkin lymphoma)Cardiovascular disease (risk marker for ischemic stroke)
05

Safety considerations

no therapeutic agents targeting SERPINA9 reported; challenges could arise from broad inhibition of protease networks in blood/immune system, but not reported directly
06

Biomarkers

Diagnostic biomarker for germinal center B-cell signature in specific lymphomasPrognostic biomarker in lymphoid malignancies

Beyond the preview

Go deeper on Serpin family A member 9 (SERPINA9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family A member 9 (SERPINA9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call